Venture Life Group plc (LON:VLG - Get Free Report) insider Jerry Randall bought 50,000 shares of the firm's stock in a transaction on Wednesday, July 2nd. The shares were purchased at an average price of GBX 59 ($0.81) per share, for a total transaction of £29,500 ($40,262.04).
Venture Life Group Price Performance
VLG stock traded down GBX 0.25 ($0.00) on Friday, reaching GBX 60.50 ($0.83). The company had a trading volume of 192,088 shares, compared to its average volume of 374,266. The company's fifty day moving average is GBX 50.06 and its 200 day moving average is GBX 42.64. The company has a market cap of £77.09 million, a P/E ratio of 102.67, a PEG ratio of 5.67 and a beta of 0.30. The company has a debt-to-equity ratio of 28.45, a quick ratio of 1.48 and a current ratio of 2.22. Venture Life Group plc has a 1 year low of GBX 32 ($0.44) and a 1 year high of GBX 63 ($0.86).
Venture Life Group (LON:VLG - Get Free Report) last released its quarterly earnings results on Monday, June 30th. The company reported GBX 3.96 ($0.05) earnings per share (EPS) for the quarter. Venture Life Group had a net margin of 1.44% and a return on equity of 0.99%. On average, research analysts forecast that Venture Life Group plc will post 6.1391542 earnings per share for the current year.
Venture Life Group Company Profile
(
Get Free Report)
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market.
With operations in the UK, The Netherlands and Italy, the Group's product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women's intimate healthcare, fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples.
Further Reading
Before you consider Venture Life Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Venture Life Group wasn't on the list.
While Venture Life Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
